Journal
JOURNAL OF PINEAL RESEARCH
Volume 61, Issue 2, Pages 241-250Publisher
WILEY-BLACKWELL
DOI: 10.1111/jpi.12344
Keywords
K+-Cl- cotransporter-2; melatonin; neuronal apoptosis; neuroprotection; traumatic brain injury
Categories
Funding
- National Natural Science Foundation of China [81371433, 81371369]
- Research Fund for the Doctoral Program of Higher Education of China [20120101120030]
- Zhejiang Provincial Medical Science and Technology Planning Project [2012RCA030, 2013KYA088]
- Zhejiang Provincial Education Planning Project [Y201226287]
- Zhejiang Provincial Natural Science Foundation of China [Y13H090007, LY13H090002]
Ask authors/readers for more resources
Traumatic brain injury (TBI) initiates a complex cascade of neurochemical and signaling changes that leads to neuronal apoptosis, which contributes to poor outcomes for patients with TBI. The neuron-specific K+-Cl- cotransporter-2 (KCC2), the principal Cl- extruder in adult neurons, plays an important role in Cl- homeostasis and neuronal function. This present study was designed to investigate the expression pattern of KCC2 following TBI and to evaluate whether or not melatonin is able to prevent neuronal apoptosis by modulating KCC2 expression in a Sprague Dawley rat controlled cortical impact model of TBI. The time course study showed decreased mRNA and protein expression of KCC2 in the ipsilateral peri-core parietal cortex after TBI. Double immunofluorescence staining demonstrated that KCC2 is located in the plasma membrane of neurons. In addition, melatonin (10mg/kg) was injected intraperitoneally at 5minutes and repeated at 1, 2, 3, and 4hours after brain trauma, and brain samples were extracted 24hours after TBI. Compared to the vehicle group, melatonin treatment altered the down-regulation of KCC2 expression in both mRNA and protein levels after TBI. Also, melatonin treatment increased the protein levels of brain-derived neurotrophic factor (BDNF) and phosphorylated extracellular signal-regulated kinase (p-ERK). Simultaneously, melatonin administration ameliorated cortical neuronal apoptosis, reduced brain edema, and attenuated neurological deficits after TBI. In conclusion, our findings suggested that melatonin restores KCC2 expression, inhibits neuronal apoptosis and attenuates secondary brain injury after TBI, partially through activation of BDNF/ERK pathway.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available